The application of continuous positive airway pressure in an obstructive sleep apnea syndrome accompanied by subconjunctival hemorrhage secondary to hypertensive episodes: A case report

Bikemgül Özkara (Ankara, Turkey), Bikemgul Ozkara, Haldun Sevketbeyoglu, Dilaver Tas, Devrim Deniz

Source: International Congress 2015 – To treat or not to treat? Sleep-disordered breathing II
Session: To treat or not to treat? Sleep-disordered breathing II
Session type: Thematic Poster Session
Number: 2417
Disease area: Sleep and breathing disorders

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Bikemgül Özkara (Ankara, Turkey), Bikemgul Ozkara, Haldun Sevketbeyoglu, Dilaver Tas, Devrim Deniz. The application of continuous positive airway pressure in an obstructive sleep apnea syndrome accompanied by subconjunctival hemorrhage secondary to hypertensive episodes: A case report. Eur Respir J 2015; 46: Suppl. 59, 2417

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The effect of continuous positive airway pressure on basal metabolism rate in patients with severe obstructive sleep apnea syndrome
Source: International Congress 2015 – Ring of fire: inflammation and metabolism in sleep-disordered breathing
Year: 2015



Efficacy of continuous positive airway pressure treatment to resistant hypertension in patients with obstructive sleep apnea syndrome
Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Year: 2008


Relationship between aldosterone and the metabolic syndrome in patients with obstructive sleep apnea: Effect of continuous positive airway pressure treatment
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013


Efficacy of continuous positive airway pressure in treatment of patients with bradyarrhythmias associated with obstructive sleep apnoea syndrome
Source: Annual Congress 2006 - Cardiovascular consequences of obstructive sleep apnoea
Year: 2006

Effects of continuous positive airway pressure therapy in patients with severe obstructive sleep apnea and endothelial dysfunction on 24-hour blood pressure profile
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015


Amelioration of immune system activation in obstructive sleep apnea syndrome patients after continuous positive airway pressure treatment
Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea
Year: 2008

The association between hypertension and neutrophil to lymphocyte ratio in patients with obstructive sleep apnea syndrome
Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels
Year: 2016

Pericardial effusion in patients with obstructive sleep apnea syndrome without daily hypoxemia and pulmonary arterial hypertension
Source: International Congress 2016 – Comorbid sleep apnoea in specific clinical entities and differential diagnosis of sleep disorders
Year: 2016


Cognitive function was improved after continuous positive airway pressure treatment in obstructive sleep apnea syndrome
Source: International Congress 2016 – Technical aspects, compliance, and adherence to positive airway pressure in sleep apnoea
Year: 2016


The role of compliance with positive airway pressure use on blood pressure in patients with obstructive sleep apnea: Is longer use a key-factor?
Source: International Congress 2015 – Paediatric and adult sleep-disordered breathing: from inflammation to treatment and telemedicine
Year: 2015


Predictors of continuous positive airway pressure adherence in obstructive sleep apnea syndrome
Source: International Congress 2017 – Inhalers and their use
Year: 2017


High flow-nasal cannula oxygen treatment in patients with concomitant severe chronic obstructive pulmonary diseases and mild-moderate  sleep apnea  (overlap syndrome).
Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Year: 2020

Recommendations for the management of patients with obstructive sleep apnoea and hypertension
Source: Eur Respir J 2013; 41: 523-538
Year: 2013



Effect of continuous positive airway pressure therapy on metabolic control in patients with morbid obesity and obstructive sleep apnoea
Source: Annual Congress 2013 –Burn after reading: inflammation in sleep disordered breathing
Year: 2013


Treatment of obstructive sleep apnoea with nasal continuous positive airway pressure in stroke
Source: Eur Respir J 2001; 18: 623-629
Year: 2001



Impact of CPAP-therapy on cardiac structure and function in patients with obstructive sleep apnea syndrome and coprevalent arterial hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 817s
Year: 2006

Complete blood count alterations after 6 months of continuous positive airway pressure treatment in patients with severe obstructive sleep apnea
Source: Annual Congress 2013 –Sleep disordered breathing in special situations I
Year: 2013


Effect of continuous positive airway pressure treatment on hypoadiponectinemia in male patients with obstructive sleep apnea syndrome
Source: Annual Congress 2005 - Metabolic control in OSA
Year: 2005


Metabolic syndrome, systemic inflammation and oxidative stress in patients with severe obstructive sleep apnea: effects of CPAP
Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Year: 2008


Treatment with CPAP reduces mortality in patients with obstructive sleep apnoea syndrome within less than 3 years
Source: Annual Congress 2006 - Therapeutic effects in obstructive sleep apnoea
Year: 2006